We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
Cap. Flow
+$149M
Cap. Flow %
2.07%
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$40.6M
2
ADSK icon
Autodesk
ADSK
+$38.8M
3
INTU icon
Intuit
INTU
+$37.1M
4
ECL icon
Ecolab
ECL
+$35.6M
5
KO icon
Coca-Cola
KO
+$35.1M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$51.9M
2
EOG icon
EOG Resources
EOG
+$33.8M
3
DATA
Tableau Software, Inc.
DATA
+$32M
4
MSFT icon
Microsoft
MSFT
+$29.8M
5
F icon
Ford
F
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.68%
3 Consumer Discretionary 13.74%
4 Industrials 11.53%
5 Healthcare 11.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAGP icon
476
Plains GP Holdings
PAGP
$5.23B
$2.67M 0.04%
106,900
+3,200
+3% +$77.3K
MMI icon
477
Marcus & Millichap
MMI
$1.15B
$2.65M 0.04%
85,998
+6,730
+8% +$244K
TBBK icon
478
The Bancorp
TBBK
$2.79B
$2.64M 0.04%
295,586
-28,059
-9% -$258K
LEA icon
479
Lear
LEA
$7.19B
$2.63M 0.04%
+18,898
New +$2.65M
LNG icon
480
Cheniere Energy
LNG
$56.5B
$2.63M 0.04%
+38,420
New +$2.54M
PRNB
481
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$2.63M 0.04%
79,202
+46,357
+141% +$1.45M
PRTA icon
482
Prothena Corp
PRTA
$458M
$2.57M 0.04%
243,291
+90,803
+60% +$933K
AXE
483
DELISTED
Anixter International Inc
AXE
$2.56M 0.04%
42,903
-93,034
-68% -$5.48M
XOM icon
484
ExxonMobil
XOM
$651B
$2.55M 0.04%
33,324
+6,200
+23% +$480K
OXFD
485
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.52M 0.03%
183,459
-4,570
-2% -$69.9K
CCRN
486
DELISTED
Cross Country Healthcare
CCRN
$2.44M 0.03%
260,315
+215,541
+481% +$1.66M
RDUS
487
DELISTED
Radius Recycling
RDUS
$2.44M 0.03%
+93,311
New +$2.22M
BHF icon
488
Brighthouse Financial
BHF
$3.63B
$2.43M 0.03%
+66,140
New +$2.56M
GOGO icon
489
Gogo Inc
GOGO
$515M
$2.43M 0.03%
609,636
+68,800
+13% +$334K
VRTV
490
DELISTED
VERITIV CORPORATION
VRTV
$2.41M 0.03%
123,996
+14,640
+13% +$337K
UHAL icon
491
U-Haul Holding Co
UHAL
$14B
$2.4M 0.03%
63,520
-14,130
-18% -$538K
HQY icon
492
HealthEquity
HQY
$7.91B
$2.4M 0.03%
36,679
+12,279
+50% +$855K
GLDD
493
DELISTED
Great Lakes Dredge & Dock
GLDD
$2.4M 0.03%
217,031
+206,631
+1,987% +$2.13M
BRSL
494
Brightstar Lottery PLC
BRSL
$1.91B
$2.39M 0.03%
184,000
-22,800
-11% -$310K
RLGT icon
495
Radiant Logistics
RLGT
$416M
$2.37M 0.03%
385,374
+90,514
+31% +$591K
SITC icon
496
SITE Centers
SITC
$230M
$2.35M 0.03%
227,639
+68,702
+43% +$720K
FRGI
497
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$2.34M 0.03%
178,324
-52,960
-23% -$707K
BMRC icon
498
Bank of Marin Bancorp
BMRC
$466M
$2.33M 0.03%
56,745
-283
-0.5% -$11.9K
GSBC icon
499
Great Southern Bancorp
GSBC
$863M
$2.33M 0.03%
38,880
+5,140
+15% +$292K
FMBI
500
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$2.31M 0.03%
112,648
-7,400
-6% -$153K

Similar funds

Jacobs Levy Equity Management's Q2 2019 Portfolio in Review

As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
  • Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
  • Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
  • Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
  • Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
  • Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
  • Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.